Skip to main content
    I

    Intelligent Bio Solutions Inc. (INBS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.52
    -0.24 (-13.64%)

    Market Cap: $5.84M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Intelligent Bio Solutions Inc. (INBS) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Intelligent Bio Solutions reported EPS of -$0.86. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    39%(7/18)
    Avg Surprise
    -80.15%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.36
    Range-$1.36 - -$1.36
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$1.360.0%
    30d ago-$1.360.0%
    7d ago-$1.360.0%
    Current-$1.36
    Revenue Consensus
    $1.40M
    Range$1.40M - $1.40M
    1 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$1.33
    Range-$1.33 - -$1.33
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$1.330.0%
    30d ago-$1.330.0%
    7d ago-$1.330.0%
    Current-$1.33
    Revenue Consensus
    $1.50M
    Range$1.50M - $1.50M
    1 analysts

    Next Report

    INBS's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 18 quarters below that had an estimate, INBS beat 7 and missed 11. Revenue for the quarter ended Sep 30, 2026 was $1.39M, up 25.2% from $1.11M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.86-$1.31-$1.31 - -$1.31N/AN/AN/A10 up, 0 downNov 10, 2026$1.39M
    Jun 30, 2026-$0.90-$1.58-$1.58 - -$1.58+43.04%BeatN/A10 up, 1 downAug 19, 2026$1.15M
    Mar 31, 2026-$1.80$1.40N/A-228.57%MissN/AN/AN/AMay 13, 2026$1.06M
    Dec 31, 2025-$2.82-$0.16N/AN/AN/AN/AN/AN/AFeb 12, 2026$896774
    Sep 30, 2025-$0.35-$0.27N/A-29.63%MissN/AN/AN/ANov 12, 2025$1.11M
    Jun 30, 2025-$0.44$0.08N/A-650.00%MissN/AN/AN/AAug 15, 2025$843884
    Mar 31, 2025-$0.44-$0.10N/A-340.00%MissN/A10 up, 0 downMay 13, 2025$728867
    Dec 31, 2024-$0.50-$0.27N/A-85.19%MissN/A10 up, 0 downFeb 13, 2025$607494
    Sep 30, 2024-$0.70-$0.53N/A-32.08%MissN/AN/A0 up, 0 downNov 7, 2024$872287
    Jun 30, 2024-$1.34-$0.51N/A-162.75%MissN/AN/A0 up, 0 downSep 19, 2024$727824
    Mar 31, 2024-$14.30-$8.70-$8.70 - -$8.70-64.37%MissN/A10 up, 0 downMay 8, 2024$823800
    Dec 31, 2023-$20.70-$32.40N/A+36.11%BeatN/A10 up, 0 downFeb 9, 2024$764063
    Sep 30, 2023-$1.04-$7.68N/A+86.45%BeatN/AN/A0 up, 0 downNov 8, 2023$796094
    Jun 30, 2023-$229.20-$178.80-$199.28 - -$158.46-28.19%MissN/A20 up, 0 downAug 24, 2023$443135
    Mar 31, 2023-$686.40-$328.80-$328.93 - -$168.07-108.76%MissN/A20 up, 0 downMay 11, 2023$457058
    Dec 31, 2022-$55.20-$264.00N/A+79.09%BeatN/A10 up, 0 downFeb 14, 2023$356679
    Sep 30, 2022-$0.08-$0.10N/A+20.00%BeatN/AN/A0 up, 0 downNov 9, 2022N/A
    Jun 30, 2022-$336.00-$432.00N/A+22.22%BeatN/AN/AN/AAug 31, 2022N/A
    Mar 31, 2022-$216.00-$384.00N/A+43.75%BeatN/AN/AN/AMay 10, 2022$192500
    Dec 31, 2021-$552.00-$384.00N/A-43.75%MissN/AN/AN/AFeb 10, 2022$177791
    Sep 30, 2021-$0.27N/AN/AN/AN/AN/AN/AN/ANov 12, 2021N/A
    Jun 30, 2021-$0.07N/AN/AN/AN/AN/AN/AN/ASep 15, 2021$1.61M
    Mar 31, 2021-$0.27N/AN/AN/AN/AN/AN/AN/AMay 13, 2021$34290
    Dec 31, 2020-$0.23N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$283037
    Sep 30, 2019-$0.09N/AN/AN/AN/AN/AN/AN/ANov 29, 2019N/A
    Jun 30, 2019-$0.19N/AN/AN/AN/AN/AN/AN/AJul 5, 2019N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$5.87, after -$2.08 the year before. It was -$0.19 for the year ended Jun 30, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$5.87N/A
    Jun 30, 2025-$2.08N/A
    Jun 30, 2024-$37.38N/A
    Jun 30, 2023-$970.88N/A
    Jun 30, 2022-$1,104.27N/A
    Jun 30, 2021-$0.66N/A
    Jun 30, 2019-$0.19N/A

    Frequently Asked Questions About INBS

    What EPS do analysts expect from INBS next quarter?

    The consensus EPS estimate for Intelligent Bio Solutions for the quarter ending Dec 31, 2026 is -$1.36 from 1 analyst, with estimates from -$1.36 to -$1.36.

    How often does INBS beat earnings estimates?

    Intelligent Bio Solutions beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -185.65%.